These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1974818)

  • 21. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
    Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
    Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantity of antibody synthesized in a single cell during the primary immune response.
    Henss J; Bodemer W; Batsford SR; Vogt A
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):381-7. PubMed ID: 190809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc receptors on IgM and IgG antibody-forming cells in an early immune response.
    Kakiuchi T; Nariuchi H; Matsuhashi T
    Cell Immunol; 1981 Jun; 61(1):124-33. PubMed ID: 7020953
    [No Abstract]   [Full Text] [Related]  

  • 25. The stimulatory and inhibitory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Niimi M; Takahara J; Sato M; Murao K; Kawanishi K
    Life Sci; 1993; 53(4):305-13. PubMed ID: 8100980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement and suppression in production of IgM-antibody in mice treated with purified saponins.
    Mita A; Shida R; Kasai N; Shoji J
    Biomedicine; 1979 Dec; 31(8):223-7. PubMed ID: 394767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low-molecular homogeneous thymus fraction stimulating immunogenesis].
    Belokrylov GA; Morozov VG; Khavinson VKh; Sofronov BN
    Biull Eksp Biol Med; 1977 Jul; 84(7):56-8. PubMed ID: 560891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of carminomycin on the immunological reactivity of the body].
    Gol'dberg ED; Mikhaĭlova TN; Zinger GV; Shubina TS; Kozlova IuG
    Antibiotiki; 1977 Aug; 22(8):734-9. PubMed ID: 334052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the dopamine D-2 receptor agonist, LY 171555, on radial arm maze performance in rats.
    Levin ED; Bowman RE
    Pharmacol Biochem Behav; 1986 Nov; 25(5):1117-9. PubMed ID: 2947250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the amount of antibody-forming and rosette-forming cells in different states of natural immunity in mice].
    Abazbekov SK
    Zdravookhr Kirg; 1976; (5):38-40. PubMed ID: 13562
    [No Abstract]   [Full Text] [Related]  

  • 31. Conditions for the development of IgM- and IgG-antibody-secreting cells from primed mouse splenocytes in vitro.
    Maizels RM; Dresser DW
    Immunology; 1977 May; 32(5):793-801. PubMed ID: 324905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in the number of splenic plaque forming cells with length of gestation in untreated pregnant mice.
    Mattsson R
    Dev Comp Immunol; 1982; 6(2):339-48. PubMed ID: 7047249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mode of action of mycobacterial adjuvants. III. The clonal nature of antibody formation and the effect of mycobacterial adjuvant on antibody-forming cell clones.
    Koashi O; Ishibashi T; Tanaka A; Sugiyama K
    Jpn J Exp Med; 1975 Aug; 45(4):247-53. PubMed ID: 810609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specialization of antibody forming cells.
    Brahmi Z; Merchant B
    Arch Inst Pasteur Alger; 1972-1973; 50-51():65-85. PubMed ID: 4620616
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic and immunologic effects of iodoacetate in mature AKR mice.
    Rheins MS; Barker AD
    Experientia; 1973 Apr; 29(4):476-7. PubMed ID: 4575260
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of bacterial polysaccharide on the primary and secondary immunologic response following immunization with sheep erythrocytes].
    Tumanian MA; Pershin SV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Nov; (11):33-8. PubMed ID: 574696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptides in the immunomodulation: substance P-induced stimulation of immune response in mice.
    Cheido M; Idova G
    Int J Immunopharmacol; 1997; 19(9-10):529-33. PubMed ID: 9637349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface antigens of murine IgM and IgG forming cells.
    Mizumoto T; Namba Y; Hanaoka M
    Acta Pathol Jpn; 1974 May; 24(3):345-55. PubMed ID: 4137221
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of the late stages of the immune process of cells capable of transformation into antibody forming cells without dividing].
    Agadzhanian MG; Gurvich AE; Grigor'eva OS
    Dokl Akad Nauk SSSR; 1978; 242(4):968-70. PubMed ID: 569042
    [No Abstract]   [Full Text] [Related]  

  • 40. TL 333, a benzhydro[g]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptor.
    Itoh Y; Goldman ME; Kebabian JW
    Eur J Pharmacol; 1985 Jan; 108(1):99-101. PubMed ID: 3979438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.